| Pharmacological Effects of Natural Compounds | Lifetime | 55 | CN 13 | 99.31 |
| Ginseng Biological Effects and Applications | Lifetime | 22 | CN 14 | 99.39 |
| Traditional Chinese Medicine Analysis | Lifetime | 51 | CN 42 | 99.04 |
| Natural product bioactivities and synthesis | Lifetime | 148 | CN 32 | 99.06 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 25 | CN 1 | 98.20 |
| Advanced Glycation End Products research | Lifetime | 237 | CN 22 | 96.73 |
| Chromatography in Natural Products | Lifetime | 151 | CN 37 | 96.92 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 426 | CN 25 | 96.89 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 207 | CN 2 | 95.66 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 121 | CN 30 | 92.83 |
| Biological Activity of Diterpenoids and Biflavonoids | Lifetime | 233 | CN 35 | 94.35 |
| Natural Antidiabetic Agents Studies | Lifetime | 829 | CN 43 | 94.05 |
| Traditional Chinese Medicine Studies | Lifetime | 535 | CN 321 | 90.77 |
| Lipid metabolism and disorders | Lifetime | 996 | CN 53 | 91.21 |
| Flavonoids in Medical Research | Lifetime | 309 | CN 126 | 87.56 |
| Hydrogen's biological and therapeutic effects | Lifetime | 303 | CN 77 | 85.38 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 262 | CN 44 | 85.24 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 444 | CN 296 | 78.96 |
| Antioxidants, Aging, Portulaca oleracea | Lifetime | 92 | CN 37 | 80.22 |
| Phytochemistry and biological activity of medicinal plants | Lifetime | 635 | CN 159 | 78.98 |
| Ginger and Zingiberaceae research | Lifetime | 910 | CN 141 | 78.16 |
| Plant-derived Lignans Synthesis and Bioactivity | Lifetime | 695 | CN 172 | 78.73 |
| Wood and Agarwood Research | Lifetime | 434 | CN 79 | 79.00 |
| Biological and pharmacological studies of plants | Lifetime | 797 | CN 396 | 73.73 |
| Tannin, Tannase and Anticancer Activities | Lifetime | 678 | CN 72 | 67.78 |
| Paraquat toxicity studies and treatments | Lifetime | 925 | CN 198 | 46.59 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 9 | CN 3 | 98.52 |
| Ginseng Biological Effects and Applications | 2021-2025 | 8 | CN 6 | 98.41 |
| Natural product bioactivities and synthesis | 2021-2025 | 73 | CN 41 | 95.73 |
| Advanced Glycation End Products research | 2021-2025 | 34 | CN 18 | 93.77 |
| Natural Antidiabetic Agents Studies | 2021-2025 | 206 | CN 20 | 92.26 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 30 | CN 2 | 91.80 |
| Phytoestrogen effects and research | 2021-2025 | 72 | CN 24 | 88.30 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 424 | CN 53 | 88.67 |
| Polysaccharides and Plant Cell Walls | 2021-2025 | 923 | CN 608 | 78.65 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 639 | CN 563 | 70.13 |
| Biochemical effects in animals | 2021-2025 | 824 | CN 434 | 70.43 |
| Food Quality and Safety Studies | 2021-2025 | 811 | CN 563 | 70.40 |
| Traditional Chinese Medicine Studies | 2021-2025 | 545 | CN 399 | 64.20 |
| Lipid metabolism and disorders | 2021-2025 | 831 | CN 243 | 61.92 |
| Flavonoids in Medical Research | 2021-2025 | 251 | CN 97 | 59.09 |
| Paraoxonase enzyme and polymorphisms | 2021-2025 | 86 | CN 3 | 59.97 |
| Antioxidants, Aging, Portulaca oleracea | 2021-2025 | 166 | CN 80 | 34.56 |
